SeaStar Medical Holdings Shares Are Trading Higher After the Company Announced Updates on the Acute Kidney Injury Programs and the Commercial Launch of Its Quelimmune Pediatric Device
SeaStar Medical Holdings宣佈了急性腎損傷項目的最新情況以及其Quelimmune兒科設備的商業推出後,該公司股價走高